Literature DB >> 18768859

Involvement of LEK1 in dendritic cell regulation of T cell immunity against Chlamydia.

Qing He1, Francis O Eko, Deborah Lyn, Godwin A Ananaba, Claudiu Bandea, Joseph Martinez, Kahaliah Joseph, Kathy Kellar, Carolyn M Black, Joseph U Igietseme.   

Abstract

We investigated the hypothesis that the enhanced Ag-presenting function of IL-10-deficient dendritic cells (DCs) is related to specific immunoregulatory cytoskeletal molecules expressed when exposed to Ags. We analyzed the role of a prominent cytoskeletal protein, LEK1, in the immunoregulation of DC functions; specifically cytokine secretion, costimulatory molecule expression, and T cell activation against Chlamydia. Targeted knockdown of LEK1 expression using specific antisense oligonucleotides resulted in the rapid maturation of Chlamydia-exposed DCs as measured by FACS analysis of key activation markers (i.e., CD14, CD40, CD54, CD80, CD86, CD197, CD205, and MHC class II). The secretion of mostly Th1 cytokines and chemokines (IL-1a, IL-9, IL-12, MIP-1a, and GM-CSF but not IL-4 and IL-10) was also enhanced by blocking of LEK1. The function of LEK1 in DC regulation involves cytoskeletal changes, since the dynamics of expression of vimentin and actin, key proteins of the cellular cytoskeleton, were altered after exposure of LEK1 knockdown DCs to Chlamydia. Furthermore, targeted inhibition of LEK1 expression resulted in the enhancement of the immunostimulatory capacity of DCs for T cell activation against Chlamydia. Thus, LEK1 knockdown DCs activated immune T cells at least 10-fold over untreated DCs. These results suggest that the effect of IL-10 deficiency is mediated through LEK1-related events that lead to rapid maturation of DCs and acquisition of the capacity to activate an elevated T cell response. Targeted modulation of LEK1 expression provides a novel strategy for augmenting the immunostimulatory function of DCs for inducing an effective immunity against pathogens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18768859      PMCID: PMC2556357          DOI: 10.4049/jimmunol.181.6.4037

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  Dendritic cells: the bare bones of immunity.

Authors:  S Burns; A J Thrasher
Journal:  Curr Biol       Date:  2004-11-23       Impact factor: 10.834

2.  Cytoplasmic LEK1 is a regulator of microtubule function through its interaction with the LIS1 pathway.

Authors:  Victor Soukoulis; Samyukta Reddy; Ryan D Pooley; Yuanyi Feng; Christopher A Walsh; David M Bader
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

Review 3.  Dendritic cells: understanding immunogenicity.

Authors:  Ralph M Steinman
Journal:  Eur J Immunol       Date:  2007-11       Impact factor: 5.532

Review 4.  Ins and outs of dendritic cells.

Authors:  Danita H Schuurhuis; Nathalie Fu; Ferry Ossendorp; Cornelis J M Melief
Journal:  Int Arch Allergy Immunol       Date:  2006-03-13       Impact factor: 2.749

5.  Molecular basis for the potency of IL-10-deficient dendritic cells as a highly efficient APC system for activating Th1 response.

Authors:  Qing He; Terri T Moore; Francis O Eko; Deborah Lyn; Godwin A Ananaba; Amy Martin; Shailesh Singh; Lillard James; Jonathan Stiles; Carolyn M Black; Joseph U Igietseme
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

6.  The cloning and analysis of LEK1 identifies variations in the LEK/centromere protein F/mitosin gene family.

Authors:  R L Goodwin; L M Pabón-Peña; G C Foster; D Bader
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

7.  Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines.

Authors:  Qing He; Luis Martinez-Sobrido; Francis O Eko; Peter Palese; Adolfo Garcia-Sastre; Deborah Lyn; Daniel Okenu; Claudiu Bandea; Godwin A Ananaba; Carolyn M Black; Joseph U Igietseme
Journal:  Immunology       Date:  2007-04-23       Impact factor: 7.397

Review 8.  Immune-mediated control of Chlamydia infection.

Authors:  Nadia R Roan; Michael N Starnbach
Journal:  Cell Microbiol       Date:  2007-11-02       Impact factor: 3.715

Review 9.  Vaccines for Chlamydia infections of the female genital tract.

Authors:  Louise M Hafner; Celia McNeilly
Journal:  Future Microbiol       Date:  2008-02       Impact factor: 3.165

10.  Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes.

Authors:  J Zhang; A Shehabeldin; L A da Cruz; J Butler; A K Somani; M McGavin; I Kozieradzki; A O dos Santos; A Nagy; S Grinstein; J M Penninger; K A Siminovitch
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

View more
  3 in total

1.  Interleukin-10 modulates antigen presentation by dendritic cells through regulation of NLRP3 inflammasome assembly during Chlamydia infection.

Authors:  Yusuf Omosun; Danielle McKeithen; Khamia Ryans; Caroline Kibakaya; Uriel Blas-Machado; Duo Li; Rajesh Singh; Koichi Inoue; Zhi-Gang Xiong; Francis Eko; Carolyn Black; Joseph Igietseme; Qing He
Journal:  Infect Immun       Date:  2015-09-14       Impact factor: 3.441

2.  Chlamydial infection in vitamin D receptor knockout mice is more intense and prolonged than in wild-type mice.

Authors:  Qing He; Godwin A Ananaba; John Patrickson; Sidney Pitts; Yeming Yi; Fengxia Yan; Francis O Eko; Deborah Lyn; Carolyn M Black; Joseph U Igietseme; Myrtle Thierry-Palmer
Journal:  J Steroid Biochem Mol Biol       Date:  2012-11-29       Impact factor: 4.292

3.  The immunoregulatory role of alpha enolase in dendritic cell function during Chlamydia infection.

Authors:  Khamia Ryans; Yusuf Omosun; Danielle N McKeithen; Tankya Simoneaux; Camilla C Mills; Nathan Bowen; Francis O Eko; Carolyn M Black; Joseph U Igietseme; Qing He
Journal:  BMC Immunol       Date:  2017-05-19       Impact factor: 3.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.